Study of L606 for lung disease with high blood pressure in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests a new treatment called L606 for people who have both a type of lung disease (ILD) and high blood pressure in the lungs (PH). The goal is to see if it is safe and helps with exercise and breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a confirmed lung disease called ILD, diagnosed with a CT scan of your chest.
- You have high blood pressure in your lungs, confirmed by a heart catheterization test.
- You can walk at least 150 meters (about 1.5 football fields) in 6 minutes.
- You do not have other types of high blood pressure in your lungs or significant heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called LAM-001 for people with high blood pressure in the lungs caused by lung scarring. It aims to see if it can improve symptoms and help you feel better.
This trial tests a new medicine called TX000045 for people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug can help improve breathing and daily function.
This study tests a new dry powder inhaled medicine called LIQ861 for people with pulmonary hypertension related to lung scarring (PH-ILD). If you are already taking an inhaled treprostinil treatment but need better control, this trial may help you switch to a potentially easier-to-use version.
This study tests an investigational medicine called LTP001 for pulmonary arterial hypertension (PAH). Part A checks safety in healthy volunteers, and Part B tests if it helps people with PAH by improving blood flow in the lungs.
This trial tests an investigational drug called NS-863 for people who have both interstitial lung disease (scarring of the lungs) and pulmonary hypertension (high blood pressure in the lungs). The goal is to see if the drug can help improve your condition.
This trial tests an investigational medicine called L608 in healthy volunteers to check its safety and how the body processes it. It may help researchers understand the right dose for future studies.
Hear when a new Pulmonary Hypertension Due to Lung Disease (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.